首页> 外文OA文献 >Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management
【2h】

Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management

机译:粘多糖贮积症患者的心脏疾病:表现,诊断和治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The mucopolysaccharidoses (MPSs) are inherited lysosomal storage disorders caused by the absence of functional enzymes that contribute to the degradation of glycosaminoglycans (GAGs). The progressive systemic deposition of GAGs results in multi-organ system dysfunction that varies with the particular GAG deposited and the specific enzyme mutation(s) present. Cardiac involvement has been reported in all MPS syndromes and is a common and early feature, particularly for those with MPS I, II, and VI. Cardiac valve thickening, dysfunction (more severe for left-sided than for right-sided valves), and hypertrophy are commonly present; conduction abnormalities, coronary artery and other vascular involvement may also occur. Cardiac disease emerges silently and contributes significantly to early mortality.
机译:粘多糖贮积酶(MPS)是遗传性的溶酶体贮积病,是由于缺乏有助于糖胺聚糖(GAG)降解的功能性酶引起的。 GAG的进行性全身沉积导致多器官系统功能障碍,该功能障碍随所沉积的特定GAG和存在的特定酶突变而变化。在所有MPS综合征中都有心脏受累的报道,这是常见的早期特征,尤其是对于MPS I,II和VI的患者。通常存在心脏瓣膜增厚,功能障碍(左侧瓣膜比右侧瓣膜更严重)和肥大。传导异常,冠状动脉和其他血管受累也可能发生。心脏疾病默默出现,并显着提高了早期死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号